Proto-Oncogene Protein c-fli-1
"Proto-Oncogene Protein c-fli-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the c-ets family of transcription factors that is preferentially expressed in cells of hematopoietic lineages and vascular endothelial cells. It was originally identified as a protein that provides a retroviral integration site for integration of FRIEND MURINE LEUKEMIA VIRUS.
| Descriptor ID |
D051789
|
| MeSH Number(s) |
D12.776.260.665.400 D12.776.624.664.700.175.400 D12.776.930.720.400
|
| Concept/Terms |
Proto-Oncogene Protein c-fli-1- Proto-Oncogene Protein c-fli-1
- Proto Oncogene Protein c fli 1
- c-fli-1, Proto-Oncogene Protein
- Retroviral Integration Site Protein Fli-1
- Retroviral Integration Site Protein Fli 1
- Proto-Oncogene Proteins c-fli-1
- Proto Oncogene Proteins c fli 1
- Friend Leukemia Integration 1 Transcription Factor
- fli-1 Transcription Factor
- Transcription Factor, fli-1
- fli 1 Transcription Factor
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Protein c-fli-1".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Protein c-fli-1".
This graph shows the total number of publications written about "Proto-Oncogene Protein c-fli-1" by people in this website by year, and whether "Proto-Oncogene Protein c-fli-1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Protein c-fli-1" by people in Profiles.
-
The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma. Nat Commun. 2025 Feb 02; 16(1):1267.
-
Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding. Am J Hum Genet. 2023 03 02; 110(3):427-441.
-
The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis. Nat Commun. 2021 02 05; 12(1):821.
-
Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways. Cancer Lett. 2020 01 28; 469:195-206.
-
Genome Wide Mapping of NR4A Binding Reveals Cooperativity with ETS Factors to Promote Epigenetic Activation of Distal Enhancers in Acute Myeloid Leukemia Cells. PLoS One. 2016; 11(3):e0150450.
-
ERG and FLI1 protein expression in epithelioid sarcoma. Mod Pathol. 2014 Apr; 27(4):496-501.
-
Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature. 2012 Mar 28; 483(7391):570-5.
-
High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition. PLoS One. 2010 Nov 11; 5(11):e13943.
-
Primary Ewing sarcoma/peripheral primitive neuroectodermal tumor of the vulva. Hum Pathol. 2008 Oct; 39(10):1535-9.
-
Functional analysis of the EWS/ETS target gene uridine phosphorylase. Cancer Res. 2003 Jul 15; 63(14):4268-74.